These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30843283)

  • 21. Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.
    Deligianni E; Daniel OJ; Corkery JM; Schifano F; Lione LA
    Br J Clin Pharmacol; 2020 Mar; 86(3):505-516. PubMed ID: 31495968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs.
    Rousis N; Bade R; Romero-Sánchez I; Mueller JF; Thomaidis NS; Thomas KV; Gracia-Lor E
    Environ Int; 2023 Aug; 178():108075. PubMed ID: 37399770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
    Lin CC; Weng TI; Ng CJ; Shih CP; Hsu J; Liao YC; Yang CC; Fang CC;
    Clin Toxicol (Phila); 2022 Jun; 60(6):708-715. PubMed ID: 35315299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring psychoactive substance use at six European festivals through wastewater and pooled urine analysis.
    Bijlsma L; Celma A; Castiglioni S; Salgueiro-González N; Bou-Iserte L; Baz-Lomba JA; Reid MJ; Dias MJ; Lopes A; Matias J; Pastor-Alcañiz L; Radonić J; Turk Sekulic M; Shine T; van Nuijs ALN; Hernandez F; Zuccato E
    Sci Total Environ; 2020 Jul; 725():138376. PubMed ID: 32298891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The challenge of complex drug use: Associated use of codeine-containing medicines and new psychoactive substances in a European cross-sectional online population.
    Kimergård A; Foley M; Davey Z; Wadsworth E; Drummond C; Deluca P
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
    Zawilska JB; Andrzejczak D
    Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Growing Problem of New Psychoactive Substances (NPS).
    Madras BK
    Curr Top Behav Neurosci; 2017; 32():1-18. PubMed ID: 27571747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines.
    Palamar JJ; Acosta P
    Hum Psychopharmacol; 2020 Jan; 35(1):e2719. PubMed ID: 31909513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users.
    Morgan CJ; Noronha LA; Muetzelfeldt M; Feilding A; Curran HV
    J Psychopharmacol; 2013 Jun; 27(6):497-506. PubMed ID: 23438502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adolescent exposures to traditional and novel psychoactive drugs, reported to National Poison Data System (NPDS), 2007-2017.
    Ng PC; Banerji S; Graham J; Leonard J; Wang GS
    Drug Alcohol Depend; 2019 Sep; 202():1-5. PubMed ID: 31279256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Legislation targeting head shops selling new psychoactive substances and changes in drug-related psychiatric admissions: A national database study.
    Smyth BP; Daly A; Elmusharaf K; McDonald C; Clarke M; Craig S; Cullen W
    Early Interv Psychiatry; 2020 Feb; 14(1):53-60. PubMed ID: 30945460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine.
    Muskiewicz DE; Resendiz-Gutierrez F; Issa O; Hall FS
    Pharmacol Biochem Behav; 2020 Apr; 191():172871. PubMed ID: 32061662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the issue of Chemsex changing?
    Pirani F; Lo Faro AF; Tini A
    Clin Ter; 2019; 170(5):e337-e338. PubMed ID: 31612189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Flakka" use among high school seniors in the United States.
    Palamar JJ; Rutherford C; Keyes KM
    Drug Alcohol Depend; 2019 Mar; 196():86-90. PubMed ID: 30709657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health Implications.
    White CM
    J Clin Pharmacol; 2016 Nov; 56(11):1319-1325. PubMed ID: 27029951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
    Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
    Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Not for Human Consumption": A Descriptive Investigation into User Characteristics, Motives, and Consequences Associated with Bath Salt Use.
    Zimmerman L; Kilwein TM; Beyer D; Marks C; Looby A
    J Psychoactive Drugs; 2019; 51(3):218-224. PubMed ID: 30724703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New psychoactive substances: An actual problem or an overestimated phenomenon?
    Vaiano F; Pascali JP; Bertol E
    Forensic Sci Int; 2019 Nov; 304():109941. PubMed ID: 31574421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan.
    Tanibuchi Y; Matsumoto T; Funada D; Shimane T
    Neuropsychopharmacol Rep; 2018 Dec; 38(4):189-196. PubMed ID: 30341809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones.
    Patrick ME; O'Malley PM; Kloska DD; Schulenberg JE; Johnston LD; Miech RA; Bachman JG
    Drug Alcohol Rev; 2016 Sep; 35(5):586-90. PubMed ID: 26711540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.